EVOTEC SE

EVT
Delayed Quote. Delayed  - 08/19 11:44:00 am
25.88EUR -1.97%

Turn to zoom
Prev.25.88000000
Open26.08000000
High26.41000000
Low25.71000000
Volume269 261
Latest news
2d ago
7d ago
7d ago
7d ago
Chart EVOTEC SE
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance29,129,131,0
Spread/Res.-11%-11%-17%
Spread/Supp.6,9%23%18%
Support24,221,121,8
Financials
Sales 2022 730 M 732 M 732 M
Net income 2022 -33,5 M -33,7 M -33,7 M
Net cash 2022 62,0 M 62,2 M 62,2 M
P/E ratio 2022 235x
Yield 2022 -
Capitalization 4 573 M 4 591 M 4 591 M
EV / Sales 2022 6,18x
EV / Sales 2023 5,40x
Nbr of Employees 4 521
Free-Float 86,9%
Company
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture...
Sector :
Other Biotechnology & Medical Research
Calendar :
2022-09-06 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 25,88 €
Average target price 37,33 €
Spread / Average Target 44,3%